Geldanamycin degrades VEGFR2 protein that triggers blood vessel growth

[News]

The drug, geldanamycin, is well known for attacking a protein associated with the spread of breast cancer. However, a laboratory-based study found it also degraded a different protein that triggers blood vessel growth.

More... (http://www.news-medical.net/news/20121106/Geldanamycin-degrades-VEGFR2-protein-that-triggers-blood-vessel-growth.aspx)